Schedule 13D ownership disclosure
CTI BIOPHARMA CORP
Security class unavailable · CUSIP: 12648L601
Event date: 2022-06-07
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 8.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001072613-22-000460
- Form type
- SC 13D
- Filer
- CTI BIOPHARMA CORP
- CIK
- CIK 891293
- Filed
- Jun 17, 2022
- Reporting period
- Jun 07, 2022
- Description
- Schedule 13D beneficial ownership